Delivery Order SPE2DB20D9354-SPE2DB24FX7S5
Award Date 5/15/24
Potential Completion Date 6/6/24
Potential Value $3.4K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $10,375.53, is for the delivery of NUPLAZID 34 MG CAPSULE 30S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at $499,999,999 and valid through November...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $10,375.53 contract is for the delivery of NUPLAZID 34 MG CAPSULE 30S, a pharmaceutical product, with a period of performance through February 24, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, allowing the agency to issue delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of NUPLAZID 34 MG CAPSULE 30S, a pharmaceutical product, to support the medical supply needs of military health facilities. The contract has a ceiling value of $3,364.50 and runs through July 31, 2024. This order is issued under a larger, single-award indefinite...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,364.50 contract is for the delivery of NUPLAZID 34 MG CAPSULE 30S, a specialized pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,364.50, is for the delivery of NUPLAZID 34 MG CAPSULE 30S, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group Inc. holds a significant Indefinite Delivery Contract (IDC) with...
- This is a $3,458.51 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of NUPLAZID 34 MG CAPSULE 30S, a pharmaceutical product, with a performance period through May 1, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables...
- This is a $17,292.55 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of NUPLAZID 34 MG CAPSULE 30S, a pharmaceutical product, with a period of performance through July 14, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $3,458.51, is for the delivery of NUPLAZID 34 MG CAPSULE 30S, a specialized pharmaceutical product. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure this direct federal award. DMS...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,458.51 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of NUPLAZID 34 MG CAPSULE 30S, a pharmaceutical product, with a period of performance ending on April 9, 2025. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $10,375.53, is for the delivery of NUPLAZID 34 MG CAPSULE 30S, a specialized pharmaceutical product. The contract does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the...
- SPE2DB20D9354Indefinite Delivery Contract
- SPE2DB20D9354-SPE2DB24FX7S5Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $3,364.50 firm fixed-price contract is for the supply of NUPLAZID 34 MG CAPSULE 30S, a pharmaceutical product. The delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that allows the DLA to issue delivery orders for a wide range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. This contract has no set-aside designation.
Generated 8/14/24, 9:36 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 5/15/24 |